MicroRNA-375-mediated Regulation of ILC2 Cells Through TSLP in Allergic Rhinitis
Overview
Affiliations
Background: Studies have shown that the number and function of type II innate lymphoid cells (ILC2) in peripheral blood of allergic rhinitis (AR) children increased significantly. This study aims to evaluate the role of miR-375 in the regulation of the differentiation and function of ILC2 through both and studies.
Methods: The expression of miR-375, thymic stromal lymphopoietin (TSLP) and the frequency of ILC2 were detected and compared between AR children and controls by real-time polymerase chain reaction (PCR), enzyme-linked immunosorbnent assay (ELISA) and flow cytometry, respectively. The miR-375 mimics or inhibitors were transfected into human nasal epithelial cells (HNECs), and the production of TSLP was detected by ELISA. HNECs and ILC2s were co-cultured to explore the role of miR-375 on ILC2s. AR mice models were established to prove the effect of miR-375 on ILC2s .
Results: The expression of TSLP, miR-375, and the frequency of ILC2 were significantly higher in AR compared with controls. We found that the TSLP expression by HNECs were significantly higher when transfected with miR-375 mimics than in those transfected with miR-control and miR-375 inhibitor. In the coculture system, HNECs transfected with miR-375 mimics promote the type II cytokines production by ILC2, and this effect was blocked by anti-TSLP. Our results also showed that the miR-375 inhibitors attenuate allergic symptoms and production of type II cytokines in AR mice.
Conclusions: Our findings suggest that miR-375-mediated regulation of ILC2 cells through TSLP, providing new potential treatment target for AR.
Pang X, Xu F, Fan C, Jiang H Clin Rheumatol. 2024; 44(1):53-66.
PMID: 39604743 DOI: 10.1007/s10067-024-07250-6.
Group 2 Innate Lymphoid Cells in Allergic Rhinitis.
Wang S, Liu X, Lin X, Lv X, Zhang H J Inflamm Res. 2024; 17:8599-8610.
PMID: 39539728 PMC: 11559184. DOI: 10.2147/JIR.S485128.
Jiang Y, Hu W, Cai Z, Lin C, Ye S Mediators Inflamm. 2023; 2023:3217261.
PMID: 37207043 PMC: 10191753. DOI: 10.1155/2023/3217261.
Noncoding RNAs and Virus and Treatment in Allergic Rhinitis.
Lei Z, Feng G, Wang Z, Ning Z Evid Based Complement Alternat Med. 2022; 2022:1979447.
PMID: 36285160 PMC: 9588333. DOI: 10.1155/2022/1979447.
Role of microRNAs in type 2 diseases and allergen-specific immunotherapy.
Jakwerth C, Kitzberger H, Pogorelov D, Muller A, Blank S, Schmidt-Weber C Front Allergy. 2022; 3:993937.
PMID: 36172292 PMC: 9512106. DOI: 10.3389/falgy.2022.993937.